Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Genedrive PLC

GDR.L ✓ COMPLIANT ☆ Track — members

LSE · Healthcare · Advanced Medical Equipment & Technology ·

UK Micro Cap Analyst: N/A

Last Close

$0.02

▲ +0.00%

Market Cap $25.98M · Vol 3.61M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$25.98M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

65.00

Momentum

Beta

3.25

vs Market

52W High

$0.02

18.35% below

52W Low

$0.00

543.04% above

Volume

3.61M

Avg 4.60M

P/B

6.08

Price-to-book

ROE

N/A

Return on equity

Free Float

36.18%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Genedrive PLC (GDR.L) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does GDR.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

+6.67%

+11.63%

+1.17%

YTD

+38.74%

+42.83%

-86.24%

-96.60%

Financials & Valuation

TTM · Annual

Total Revenue	$1.31M
Net Income	$-7,183,762.00
Revenue Growth (YoY)	+62.86%
Gross Margin	100.00%
Operating Margin	-563.94%
Net Profit Margin	-548.32%
ROE	N/A
ROA · ROIC	-112.87% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	8.26
P/B	6.08
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	1.61B

Technical Indicators

50-Day SMA	$0.02
200-Day SMA	$0.01
RSI (14)	65.00
Beta	3.25
52-Week High	$0.02
52-Week Low	$0.00

Volume Today	3.61M
Avg Daily Volume (30D)	4.60M
Relative Volume	0.79x
Volatility (10D)	73.56
Volatility (30D)	87.05
Free Float	36.18%

Analyst Consensus

N/A

Current Price $0.02

Mean Target N/A

52W Low$0.00 52W High$0.02

Current

Target

$0.00 $0.02

Current Analyst target

· 0 analysts

Identifiers

ExchangeLSE

FIGIBBG001SS3PR7

ISINGB00B1VKB244

CountryUnited Kingdom

Sub-IndustryMedical Diagnostic & Testing Equipment

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

SRT.DE Sartorius AG -1.14% BIOT.ST Biotage AB +0.14% EUZ.DE Eckert & Ziegler SE -0.44% VREX Varex Imaging Corp -0.05% REG1V.HE Revenio Group Oyj +5.89%

Company Profile

genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.